secwatch.observer — SEC 8-K summary
======================================

Issuer:     MIMEDX GROUP, INC. (MDXG)
CIK:        0001376339
Form:       8-K
Filed at:   2022-09-06T23:59:59+00:00
Accession:  0001376339-22-000112
Event type: leadership
Sentiment:  negative
Materiality: 0.80
Item codes: 5.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MiMedx appoints Todd Newton interim CEO; 2022 revenue growth outlook at low end of prior range
--------------------------------------------------------------------------------

- Timothy R. Wright terminated as CEO effective immediately; K. Todd Newton appointed interim CEO.
- Board formed Search Committee to find permanent CEO; includes Behrens, Bierman, Hawkins.
- Board reduced to eight members; Newton no longer independent; Laurencin appointed to Audit Committee.
- 2022 full-year AWC product net sales expected at low end of 11-14% growth range (2021: $240M).
- Q3 2022 AWC product net sales expected mid-single-digit growth vs Q3 2021 ($62.3M); total net sales expected to grow.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1376339/000137633922000112/0001376339-22-000112-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1376339/000137633922000112/mdxg-20220903.htm
  HTML page:      https://secwatch.observer/filing/0001376339-22-000112

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer